Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price traded up 1.7% during trading on Thursday . The company traded as high as $49.86 and last traded at $49.86. 3,591 shares were traded during mid-day trading, an increase of 89% from the average session volume of 1,898 shares. The stock had previously closed at $49.04.
Hikma Pharmaceuticals Stock Up 1.7%
The business’s fifty day simple moving average is $47.71 and its 200 day simple moving average is $51.59.
Hikma Pharmaceuticals Cuts Dividend
The business also recently declared a dividend, which was paid on Monday, September 29th. Shareholders of record on Tuesday, August 19th were issued a $0.70 dividend. This represents a yield of 340.0%. The ex-dividend date was Monday, August 18th. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is presently 10.34%.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- Using the MarketBeat Dividend Yield Calculator
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- Pros And Cons Of Monthly Dividend Stocks
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
